Anne Offermann
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer-related Molecular Pathways
-
- Cancer-related molecular mechanisms research
Papers in
-
- Prostate Cancer Treatment and Research 19
- Prostate Cancer Diagnosis and Treatment 9
-
- Ubiquitin and proteasome pathways 4
- Co-authors
- Sven Perner (50 shared papers)Jutta Kirfel (26 shared papers)Julika Ribbat‐Idel (15 shared papers)Axel S. Merseburger (20 shared papers)Verena Sailer (16 shared papers)Stefan Duensing (7 shared papers)Marie C. Hupe (12 shared papers)Wenzel Vogel (9 shared papers)
- Journals
- International Journal of Molecular Sciences (5 papers)Frontiers in Medicine (4 papers)Cancers (3 papers)Oncotarget (3 papers)PLoS ONE (2 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Anne Offermann
49 papers receiving 828 citations
Peers
Comparison fields: 5 of 78
- Oncology 253
- Cancer Research 124
- Pulmonary and Respiratory Medicine 261
- Sensory Systems 36
- Immunology 126
Countries citing papers authored by Anne Offermann
This map shows the geographic impact of Anne Offermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Offermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Offermann more than expected).
Fields of papers citing papers by Anne Offermann
This network shows the impact of papers produced by Anne Offermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Offermann. The network helps show where Anne Offermann may publish in the future.
Co-authors
The 25 scholars most cited alongside Anne Offermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 120 | |
| 2 | 2020 | 61 | |
| 3 | 2018 | 53 | |
| 4 | 2016 | 48 | |
| 5 | 2019 | 46 | |
| 6 | 2022 | 35 | |
| 7 | 2014 | 33 | |
| 8 | 2016 | 29 | |
| 9 | 2021 | 28 | |
| 10 | 2017 | 28 | |
| 11 | 2013 | 26 | |
| 12 | 2013 | 26 | |
| 13 | 2019 | 26 | |
| 14 | 2016 | 23 | |
| 15 | 2020 | 20 | |
| 16 | 2015 | 18 | |
| 17 | 2022 | 18 | |
| 18 | 2021 | 16 | |
| 19 | 2020 | 16 | |
| 20 | 2015 | 14 |
About Anne Offermann
Anne Offermann is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Immunology and Cancer Research, having authored 54 papers that have together received 841 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (19 papers), Cancer Immunotherapy and Biomarkers (10 papers), Prostate Cancer Diagnosis and Treatment (9 papers), Immunotherapy and Immune Responses (5 papers), Ubiquitin and proteasome pathways (4 papers), Cancer, Lipids, and Metabolism (4 papers), Cancer-related Molecular Pathways (4 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Oncology (253 citations), Cancer Research (124 citations), Pulmonary and Respiratory Medicine (261 citations), Sensory Systems (36 citations) and Immunology (126 citations). Anne Offermann has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Sven Perner, Jutta Kirfel, Julika Ribbat‐Idel, Axel S. Merseburger, Verena Sailer, Stefan Duensing, Marie C. Hupe, Wenzel Vogel, Christian Idel and Rosemarie Krupar. Their work appears in journals such as International Journal of Molecular Sciences, Frontiers in Medicine, Cancers, Oncotarget and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.